November 3, 2026StocksTechnology·Bullish·regulatory
Cepheid receives FDA clearance for Xpert Hemorrhagic Fever Panel
Cepheid, a Danaher operating company, announced the U.S. FDA cleared its Xpert Hemorrhagic Fever Panel. The test delivers results in approximately 61 minutes from a single sample to aid rapid diagnosis of patients with relevant symptoms.
Detected & updated continuously · Source: Nebula
Story subjects